Pfizer Inc
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
Chief Executive Officers of pharmaceutical companies testify before the Senate Finance Committee on “Drug Pricing in America: A Prescription for Change, Part II” February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, chairman and CEO of AbbVie Inc; Pascal Soriot, executive director and CEO of AstraZeneca; Giovanni Caforio, chairman of […]
Read More
FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall
XBB.1.5 strain of Covid CFOTO | Future Publishing | Getty Images The U.S. Food and Drug Administration on Friday recommended that vaccine manufacturers make single-strain Covid shots for the fall that target omicron subvariant XBB.1.5, the dominant strain of the virus nationwide. “Based on the totality of the evidence, FDA has advised manufacturers who will […]
Read More
FDA advisors raise doubts about seasonal updates to Covid vaccines as with flu shots
A person receives a COVID-19 vaccination dose, during a free distribution of COVID-19 rapid test kits for those who received vaccination shots or booster shots, at Union Station on January 7, 2022 in Los Angeles, California. Mario Tama | Getty Images The U.S. Food and Drug Administration’s independent panel of advisors raised doubts about the […]
Read More
FDA advisors recommend that new Covid vaccines target an omicron XBB variant this fall
A woman receives a booster dose of the Moderna coronavirus disease (COVID-19) vaccine at a vaccination centre in Antwerp, Belgium, February 1, 2022. Johanna Geron | Reuters The U.S. Food and Drug Administration’s independent panel of advisors on Thursday recommended that updated Covid shots for the fall and winter target one of the XBB variants, […]
Read More
Oracle hits record just after 50% surge in 2023, defying tech struggles
Larry Ellison, Oracle’s chairman and technological innovation chief, speaks at the Oracle OpenWorld conference in San Francisco on September 16, 2019. Justin Sullivan | Getty Illustrations or photos Oracle is owning a minute. For many years, the databases program developer lagged powering tech rivals in making cloud technological know-how that achieved the calls for of […]
Read More
Covid vaccine maker Novavax sees a pathway to survival – but it won’t be easy
Medical syringes and Novavax logo displayed in the background are seen in this illustration photo taken in Krakow, Poland on December 2, 2021. Jakub Porzycki | NurPhoto | Getty Images Novavax has a clear message for Wall Street: The cash-strapped Covid vaccine maker sees a pathway to survival. Maryland-based Novavax said as much last month […]
Read More
Updated Covid vaccines need to target XBB omicron variants this fall, FDA staff says
Syringe with Covid-19 vaccine against the XBB Variant. Fight against virus Covid-19 Coronavirus, Vaccination and immunization. Undefined Undefined | Istock | Getty Images U.S. Food and Drug Administration staff on Monday said updated Covid boosters should target XBB omicron subvariants for the upcoming fall and winter vaccination campaign. The U.S. should use a monovalent vaccine […]
Read More
FDA approves Pfizer RSV vaccine for older adults
Luis Alvarez | Digitalvision | Getty Images The Food and Drug Administration on Wednesday approved a vaccine made by Pfizer that protects adults ages 60 and older from respiratory syncytial virus, a common pathogen that kills and hospitalizes thousands of seniors every year. Pfizer, in a statement Wednesday, said it expects to have supply available […]
Read More
ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight
Developments in cancer research will be in the spotlight as the American Society of Clinical Oncology hosts the world’s biggest cancer research conference in Chicago, starting Thursday. Investors have already caught a glimpse of the topics that will be discussed but many are eager to hear the details behind the abstracts, and no doubt there […]
Read More
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
The Food and Drug Administration on Thursday granted full approval to Pfizer’s Covid antiviral pill, Paxlovid, for adults who are at high risk of getting severely sick with the virus. Paxlovid is specifically advised for the treatment of mild to moderate Covid in adults older than 50 and people who suffer from certain medical conditions […]
Read More